Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
   G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
   G02 OTHER GYNECOLOGICALS
   G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
   G04 UROLOGICALS
     G04B UROLOGICALS
     G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
       G04CA Alpha-adrenoreceptor antagonists
         G04CA01 Alfuzosin [DG:DG00489]
         G04CA02 Tamsulosin [DG:DG00490]
         G04CA03 Terazosin [DG:DG00491]
         G04CA04 Silodosin
           D01965  Silodosin (JP17/INN) <JP/US>
         G04CA51 Alfuzosin and finasteride
         G04CA52 Tamsulosin and dutasteride
         G04CA53 Tamsulosin and solifenacin
         G04CA54 Tamsulosin and tadalafil
       G04CB Testosterone-5-alpha reductase inhibitors
       G04CX Other drugs used in benign prostatic hypertrophy
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: December 6, 2019
According to WHO's ATC 2020

» Japanese version